This is unpublished
Laboratory Research
We continue to advance understanding of the pathophysiology of kidney diseases through laboratory research that broadly examines the roles of podocytes in glomerular disease and aging in the kidney.
Dr. Stuart Shankland is part of the NIH-funded (Re) Building the Kidney consortium to leverage tissue regeneration as a treatment for kidney diseases. Organoids are an innovative approach to understanding disease pathophysiology.
The Shankland Lab investigates glomerular disease at the bedside to ultimately benefit patients. In particular, we study kidney regeneration, responses to kidney injury in disease, how potential therapies might impact outcomes at a molecular level, and how aging impacts kidney biology.